To verify our findings by a complementary approach, we measured the ability of green-fluorescent protein (GFP)-tagged LC3B protein (GFPLC3) to promote puncta formation in BC cells before and after erastin and/or bafilomycin A1 treatment. The gene discussed is MAP1LC3B; the disease is breast cancer.